Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,8212,840 of 20,252 grants

Active OTHER RESEARCH-RELATED
A Healthy Weight Intervention for Family Stress during the Early Phases of ALL Treatment: NOURISH-ALL
NATIONAL CANCER INSTITUTE University of Kansas Medical Center United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Excessive weight gain leading to obesity is common during the early phases of pediatric acute lymphoblastic leukemia (ALL) treatment, and results in higher...

$2.07M
USD
Active TRAINING, INSTITUTIONAL
Oncology-focused Postdoctoral Training in Care Delivery and Symptom Science (OPTICS)
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT The Oncology-focused Postdoctoral Training In Care Delivery and Symptom Science (OPTICS) T32 program will mentor and train physicians and scientists with P...

$5.58M
USD
Active TRAINING, INSTITUTIONAL
Graduate Program in Cancer Biology Training at Emory University
NATIONAL CANCER INSTITUTE Emory University United States 2023 – 2028

PROJECT SUMMARY Cancer represents a collection of diseases that remains the second leading cause of death in the United States. However, several recent advances in cross-disciplina...

$2.22M
USD
Active NON-SBIR/STTR RPGS
Advanced development of composite gene delivery and CAR engineering systems
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2026

SUMMARY | Cellular immunotherapy such as chimeric antigen receptor (CAR) T cells involves engineering and adoptive transfer of cells to directly target tumor cells in patient, and...

$3.96M
USD
Active RESEARCH CENTERS
Project 1: Deciphering the Dynamic Evolution of the Tumor-Neural Interface
NATIONAL CANCER INSTITUTE Massachusetts Institute of Technology United States 2023 – 2028

ABSTRACT – PROJECT 1 The central premise of our CSBC MIT/DFCI Center for Systems Biology in Glioblastoma is that high-content systems-level measurements at molecular, microscopic,...

Active RESEARCH CENTERS
Project 2: Deciphering the Dynamic Evolution of the Tumor-Immune Interface
NATIONAL CANCER INSTITUTE Massachusetts Institute of Technology United States 2023 – 2028

ABSTRACT – PROJECT 2 The central premise of our CSBC MIT/DFCI Center for Systems Biology in Glioblastoma is that high-content systems-level measurement techniques, employed across...

Active OTHER RESEARCH-RELATED
Immune control of oncogene selection in preneoplastic colon
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2028

Colon cancers develop by stepwise accumulation of oncogenic mutations in epithelial stem cells. These mutated stem cells multiply by positive selection in healthy colon for years b...

$1.85M
USD
Completed OTHER RESEARCH-RELATED
Dissecting the role of mitochondrial glutathione homeostasis in cancer
NATIONAL CANCER INSTITUTE Rockefeller University United States 2023 – 2025

Project Summary All eukaryotic cells, whether normal or cancerous, require the ability to sense changes in nutrients levels, ensuring their efficient use for survival and growth. N...

$491.9K
USD
Completed SBIR-STTR RPGS
Development of a new class of BLVRB-targeted redox therapeutics in breast cancer
NATIONAL CANCER INSTITUTE Blood Cell Technologies, Llc United States 2023 – 2025

SUMMARY Enhanced metabolic and mitochondrial activity inherent in actively proliferating cancer cells generates an excessive amount of reactive oxygen species (ROS), associated wit...

$2.85M
USD
Completed SBIR-STTR RPGS
Targeting pancreatic cancer metastases with Targefrin
NATIONAL CANCER INSTITUTE Armida Labs, Inc United States 2023 – 2025

ABSTRACT We intend to devise a novel therapeutic strategy based on a specific cancer cell receptor named EphA2, which is abundant on the surface of metastatic pancreatic cancers. O...

$4M
USD
Active TRAINING, INSTITUTIONAL
Training Grant in Precision Cancer Control
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2023 – 2028

PROJECT SUMMARY In the United States, more than 40 percent of new cancer cases can be attributed to modifiable factors. Yet, despite advances in knowledge regarding the multilevel...

$1.56M
USD
Active RESEARCH CENTERS
The Ohio State University Tobacco Center of Regulatory Science (OSU-TCORS)
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

OVERALL PROJECT SUMMARY Nicotine is the most important driver of tobacco use. The tobacco industry's manipulation of nicotine in cigarettes and smokeless tobacco led to produc...

$39.04M
USD
Completed NON-SBIR/STTR RPGS
Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2023 – 2025

Abstract Tumor-associated macrophages are key effector immune cells that promote prostate cancer progression. Studies in other cancers show that macrophage secrete cytokines, angio...

$4.23M
USD
Active RESEARCH CENTERS
The Ohio State University Tobacco Center of Regulatory Science (OSU-TCORS)
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

OVERALL PROJECT SUMMARY Nicotine is the most important driver of tobacco use. The tobacco industry's manipulation of nicotine in cigarettes and smokeless tobacco led to produc...

$39.92M
USD
Active RESEARCH CENTERS
Project 1: Manipulating E-cigarette Nicotine to Promote Public Health
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY – PROJECT 1 Historically, the tobacco industry manipulated nicotine in cigarettes to promote smoking. They are now following the same playbook for e-cigarettes (ECs...

Active RESEARCH CENTERS
Project 2: Informing oral nicotine pouch regulations to promote public health
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY – PROJECT 2 Historically, the tobacco industry manipulated nicotine concentration and form to offer a range of smokeless tobacco (ST) products to appeal to both new...

Active RESEARCH CENTERS
Project 3: Nicotine Product Claims on Appeal, Perceptions, and Use Behavior
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

SUMMARY – PROJECT 3 Oral nicotine pouches (ONPs) emerged in the U.S. in 2016, ONP brands rapidly proliferated, and sales are skyrocketing. ONPs are representative of a shift by the...

Active RESEARCH CENTERS
Project 4: A Naturalistic Observation of Electronic Cigarettes and Oral Nicotine Pouch Product Use Among Adolescents and Young Adults
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY – PROJECT 4 The tobacco product landscape changed drastically in the last decade with the proliferation of non-combustible tobacco products like e-cigarettes (ECs)...

Active RESEARCH CENTERS
Administrative Core (AC)
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY - ADMINISTRATIVE CORE The Administrative Core (AC) will provide a structure to facilitate effective and integrative interactions between the TCORS team. The AC will...

Active RESEARCH CENTERS
Career Enhancement Core
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY - CAREER ENHANCEMENT CORE The goal of the Career Enhancement Core (CEC) is to foster the development of researchers planning to engage in the field of tobacco regul...